BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17526759)

  • 1. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.
    Ochoa TJ; Chen J; Walker CM; Gonzales E; Cleary TG
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2837-41. PubMed ID: 17526759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
    Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
    Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a lysogenic bacteriophage carrying the stx(1(OX3)) gene, which is closely associated with Shiga toxin-producing Escherichia coli strains from sheep and humans.
    Koch C; Hertwig S; Lurz R; Appel B; Beutin L
    J Clin Microbiol; 2001 Nov; 39(11):3992-8. PubMed ID: 11682520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.
    Zhang X; McDaniel AD; Wolf LE; Keusch GT; Waldor MK; Acheson DW
    J Infect Dis; 2000 Feb; 181(2):664-70. PubMed ID: 10669353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
    Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
    Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.
    Grif K; Dierich MP; Karch H; Allerberger F
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):761-6. PubMed ID: 9923515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of stx2 converting bacteriophages induced from Shiga-toxin-producing Escherichia coli strains isolated from cattle.
    Muniesa M; Blanco JE; de Simón M; Serra-Moreno R; Blanch AR; Jofre J
    Microbiology (Reading); 2004 Sep; 150(Pt 9):2959-2971. PubMed ID: 15347754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial susceptibility of shiga toxin producing E coli (STEC) strains isolated from human infections and food].
    Reyes MS; Durán CT; Prado VJ
    Rev Med Chil; 2004 Oct; 132(10):1211-6. PubMed ID: 15631209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
    Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
    J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.
    Brooks JT; Sowers EG; Wells JG; Greene KD; Griffin PM; Hoekstra RM; Strockbine NA
    J Infect Dis; 2005 Oct; 192(8):1422-9. PubMed ID: 16170761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview.
    Kakoullis L; Papachristodoulou E; Chra P; Panos G
    J Infect; 2019 Aug; 79(2):75-94. PubMed ID: 31150744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterisation of Escherichia coli strains of O157 and non-O157 serogroups containing three distinct Shiga toxin genes.
    Fürst S; Scheef J; Bielaszewska M; Rüssmann H; Schmidt H; Karch H
    J Med Microbiol; 2000 Apr; 49(4):383-386. PubMed ID: 10755635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult nondiarrhea hemolytic uremic syndrome associated with Shiga toxin Escherichia coli O157:H7 bacteremia and urinary tract infection.
    Chiurchiu C; Firrincieli A; Santostefano M; Fusaroli M; Remuzzi G; Ruggenenti P
    Am J Kidney Dis; 2003 Jan; 41(1):e4.1 - e4.4. PubMed ID: 12500215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.
    Tarr PI; Gordon CA; Chandler WL
    Lancet; 2005 Mar 19-25; 365(9464):1073-86. PubMed ID: 15781103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isogenic lysogens of diverse shiga toxin 2-encoding bacteriophages produce markedly different amounts of shiga toxin.
    Wagner PL; Acheson DW; Waldor MK
    Infect Immun; 1999 Dec; 67(12):6710-4. PubMed ID: 10569798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains.
    Köhler B; Karch H; Schmidt H
    Microbiology (Reading); 2000 May; 146 ( Pt 5)():1085-1090. PubMed ID: 10832635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.